Submission Details
| 510(k) Number | K240273 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 31, 2024 |
| Decision Date | March 06, 2024 |
| Days to Decision | 35 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K240273 is an FDA 510(k) clearance for the Access Free T4, a Radioimmunoassay, Free Thyroxine (Class II — Special Controls, product code CEC), submitted by Beckman Coulter, Inc. (Chaska, US). The FDA issued a Cleared decision on March 6, 2024, 35 days after receiving the submission on January 31, 2024. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1695.
| 510(k) Number | K240273 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 31, 2024 |
| Decision Date | March 06, 2024 |
| Days to Decision | 35 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | CEC — Radioimmunoassay, Free Thyroxine |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1695 |